SRPT
Sarepta Therapeutics Inc
Price:  
123.46 
USD
Volume:  
1,033,826.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SRPT WACC - Weighted Average Cost of Capital

The WACC of Sarepta Therapeutics Inc (SRPT) is 7.8%.

The Cost of Equity of Sarepta Therapeutics Inc (SRPT) is 8.00%.
The Cost of Debt of Sarepta Therapeutics Inc (SRPT) is 5.50%.

Range Selected
Cost of equity 6.90% - 9.10% 8.00%
Tax rate 0.20% - 0.90% 0.55%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.6% - 8.9% 7.8%
WACC

SRPT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.65 0.76
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.10%
Tax rate 0.20% 0.90%
Debt/Equity ratio 0.11 0.11
Cost of debt 4.00% 7.00%
After-tax WACC 6.6% 8.9%
Selected WACC 7.8%